Paloma Partners’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Paloma Partners’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,000	Closed	-$103K	–	983
2023 Q1	$103K	Hold	10,000	–	–	﹤0.01%	687
2022 Q4	$103K	Hold	10,000	–	–	﹤0.01%	805
2022 Q3	$101K	Hold	10,000	–	–	﹤0.01%	835
2022 Q2	$100K	Hold	10,000	–	–	﹤0.01%	983
2022 Q1	$100K	Buy	+10,000	New	+$99.3K	﹤0.01%	1590

Paloma Partners's IQMD Position: Q1 2023 in Review

Paloma Partners sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 20,000 shares — an estimated $205K sold.

Paloma Partners first reported a position in IQMD in Q1 2022 and held it in 4 quarters. The position peaked at $206K in Q4 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

Paloma Partners reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Paloma Partners sold 20,000 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $205K.
Paloma Partners first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 4 quarters.
Paloma Partners's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $206K in Q4 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Paloma Partners's 13F filing for Q1 2023, filed 15 May 2023.